Neopharm Labs Inc., a leading Quebec-based full-service pharmaceutical testing laboratory, acquired Averica Discovery in November 2016. Together the companies offer services that span the full drug development cycle including R&D, method development and validation, impurity isolation and profiling, stability testing and management, and commercial testing in chemistry and microbiology. Visit www.neopharmlabs.com to learn more.
Worcester Polytechnic Institute (WPI), one the nation’s first engineering and technology universities, established a research connection with Averica in April 2013. The open-ended agreement with their Chemistry and Biochemistry Departments allow the two organizations to share their expertise on a variety of projects. Averica regularly participates in career fairs at the college, and has selected …
IRIX Pharmaceuticals is a leading small molecule contract research and manufacturing organization (CRMO) helping bring difficult to manufacture APIs to the market. In February 2014 Averica became their preferred provider for Targeted Isolation services. This has saved their clients time and money while profiling unknown impurities. Patheon acquired IRIX in April 2015.
Novatia is a contract research organization providing Averica with expert NMR data as a part of the structure elucidation of our Targeted Isolation services.
